MoneyWorks4Me

HVAX Technologies Ltd (HVAX)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: HVAX Engineering Consultancy | Small Cap | HVAX Technologies Share Price

BSE Share Price
Not Listed

HVAX Technologies Ltd (HVAX)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: HVAX Engineering Consultancy | Small Cap | HVAX Technologies Share Price

BSE Share Price
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹196 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
₹51.5
TTM Sales
₹164 Cr.
Book Value per Share
₹312.2
P/E Ratio
13.72
Lower than its 5-year historical median
Industry PE
23.4
Price to Book (P/B)
2.26
Lower than its 5-year historical median
Price to Sales (P/S)
1.20
Lower than its 5-year historical median
EV/EBITDA
9.45
Lower than its 5-year historical median
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
18.56%
Return on Capital Employed (ROCE)
20.12%
Return on Assets (ROA)
10.71%
Operating Profit Margin
10.4%
Net Profit Margin
8.99%
Gross Profit Margin
12.8%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
22.27%
Operating Profit Growth (1 Year)
-
-8.29%
Net Profit Growth (1 Year)
-
33.42%
Asset Quality
Promoter Holding
66.65%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹84 Cr.
Equity
₹2.8 Cr.
Face Value
₹10
All Time Low / High
₹0.00 / 0.00

HVAX Technologies stock performance

Key Ratios
mw4me loader

Check Before You Invest

Valuation

Undervalued

Price Trend

Semi Strong
Q.1 Is HVAX Technologies Ltd a good quality company?
HVAX Technologies Ltd is a weak quality company, based on a inconsistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does HVAX Technologies Ltd performance compare with that of its Peers?
Q.1 Revenue growth of HVAX Technologies Ltd vs industry peers?
HVAX Technologies Ltd revenue CAGR is 0.00%, compared to the industry median CAGR of %, indicating stable growth and maintaining its market share.
Q.1 Promoter shareholding and pledge status of HVAX Technologies Ltd?
Promoters hold 66.65% of the HVAX Technologies Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of HVAX Technologies Ltd over the last decade?
Over the last 1 year(s), the stock has delivered a CAGR of -23.09% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
HVAX Technologies Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation ⓘ

Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26TTM
ROCE % ⓘ39.1%33.6%27.4%29%22.4%19.7%-
Value Creation
Index ⓘ
1.81.41.01.10.60.4-

Growth Parameters ⓘ

Sales ⓘ60.868.395.9106131160160
Sales YoY Gr.-12.4%40.5%10.6%23.5%22.3%-
Adj EPS ⓘ16.72231.238.740.634.251.5
YoY Gr.-32%41.8%24.1%4.7%-15.8%-
BVPS (₹) ⓘ42.364.993151.5259.3310.9310.9
Adj Net
Profit ⓘ
3.14.15.87.911.39.514
Cash Flow from Ops. ⓘ6.3-0.8-3.6-12.2-21.9-14.2-
Debt/CF from Ops. ⓘ1.1-12-4.7-2-1.3-2.8-

CAGR ⓘ

9 Years 5 Years 3 Years 1 Years
Sales ⓘNA21.4%18.6%22.3%
Adj EPS ⓘNA15.4%3.1%-15.8%
BVPSⓘNA49%49.5%19.9%
Share Price - - - -21.4%

Key Financial Parameters ⓘ

Mar'21Mar'22Mar'23Mar'24Mar'25Mar'26TTM
Return on
Equity % ⓘ
39.541.139.632.921.91216.6
Op. Profit
Mgn % ⓘ
8.910.19.812.314.510.3NAN
Net Profit
Mgn % ⓘ
5.1667.58.65.98.9
Debt to
Equity ⓘ
0.90.810.80.40.5-
Working Cap
Days ⓘ
01651921912072670
Cash Conv.
Cycle ⓘ
01001291351542050

Valuation of HVAX Technologies - Consolidated

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Financials

PARTICULARSMar'25Mar'26
Sales131164
Operating Expenses ⓘ + 112147
Manufacturing Costs912
Material Costs79103
Employee Cost 1014
Other Costs ⓘ 1318
Operating Profit ⓘ 1917
Operating Profit Margin (%) 14.2%10.4%
Other Income ⓘ + 07
Exceptional Items ⓘ 00
Interest ⓘ 23
Depreciation ⓘ 21
Profit Before Tax ⓘ 1520
Tax ⓘ 45
Profit After Tax 1115
PAT Margin (%) 8.4%9.0%
Adjusted EPS (₹)39.851.5
Dividend Payout Ratio (%)0%0%
PARTICULARSMar'25Mar'26

Equity and Liabilities

Shareholders Fund + 7287
Share Capital ⓘ 2.782.78
Reserves ⓘ 6984
Debt +2841
Long Term Debt22
Short Term Debt2539
Minority Interest00
Trade Payables1621
Others Liabilities ⓘ 65
Total Liabilities ⓘ 121154

Fixed Assets

Net Fixed Assets ⓘ +87
Gross Block1213
Accumulated Depreciation56
CWIP ⓘ 00
Investments ⓘ 00
Inventories2142
Trade Receivables7186
Cash Equivalents 149
Others Assets ⓘ 710
Total Assets ⓘ 121154
PARTICULARSMar'25Mar'26
Cash Flow From Operating Activity ⓘ + -22-14
PBT ⓘ 1520
Adjustment ⓘ 45
Changes in Working Capital ⓘ -38-34
Tax Paid ⓘ -3-5
Cash Flow From Investing Activity ⓘ + 0-1
Capex -0-0
Net Investments 0-0
Others ⓘ 0-0
Cash Flow From Financing Activity ⓘ + 3110
Net Proceeds from Shares ⓘ 300
Net Proceeds from Borrowing ⓘ -0-0
Interest Paid ⓘ -2-3
Dividend Paid ⓘ 00
Others ⓘ 413
Net Cash Flow ⓘ 10-5
PARTICULARSMar'25Mar'26
Ratios
ROE (%)15.3418.56
ROCE (%)17.4320.12
Asset Turnover Ratio1.081.19
PAT to CFO Conversion(x)-2-0.93
Working Capital Days
Receivable Days199175.20
Inventory Days57.3069.30
Payable Days71.6064.50

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

HVAX Technologies Ltd FAQs

The current trading price of HVAX Technologies on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of HVAX Technologies stood at ₹196.3 Cr

The latest P/E ratio of HVAX Technologies as of 31-Dec-1969 is 13.73.

The latest P/B ratio of HVAX Technologies as of 31-Dec-1969 is 2.27.

The 52-week high of HVAX Technologies is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of HVAX Technologies is ₹160 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that HVAX Technologies Ltd is a below average quality company.

The key valuation ratios of HVAX Technologies Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of HVAX Technologies Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

About HVAX Technologies Ltd

HVAX Technologies (HVAX), established in 2010 and headquartered in Mumbai, is a specialized turnkey solutions provider for cleanroom and controlled environment infrastructure. The company offers comprehensive services covering design, engineering, supply, installation, testing, commissioning, and validation, enabling it to meet the requirements of highly regulated industries.

Over time, HVAX has built strong expertise in HVAC systems, modular partitions, air handling units, ducting, ceilings, doors, and Building Management Systems. This capability allows the company to cater to diverse sectors including pharmaceuticals, biotechnology, healthcare, and FMCG, where compliance, precision, and operational reliability are critical. Alongside its core turnkey offerings, HVAX provides feasibility studies, detailed engineering, and project integration services, ensuring end-to-end support for its clients.

With a steadfast commitment to global GMP standards and regulatory compliance, HVAX has earned recognition for transparency, technical strength, and execution excellence. Its international journey began with the first overseas project in Kenya in 2012, followed by the successful delivery of complex hospital and pharmaceutical infrastructure across Asia, Africa, and the Middle East. 

Business area of the company

The company is a premier engineering and controlled-environment partner. By combining turnkey design consultancy with advanced HVAC and containment integration, the company provides the scalable infrastructure necessary for industries where uptime, regulatory compliance, and safety are the primary drivers of value.

Services

  • Engineering Consultancy
  • Gap Analysis and Validation
  • Containment Consultancy
  • Technology Transfer
  • Project Feasibility

Products

  • Clean Room Partition
  • HVAC Systems
  • Containment Technology
  • Building Management Systems
  • Clean Room Equipment
  • Electrical HT/LT Panels
  • Laboratories Furniture
  • Utility Generation & Distribution
  • Pre Engineering Building.

Milestones

  • 2010: Secured first orders from leading MNCs such as Sandoz and 3M.
  • 2012: Began projects for API manufacturers including Divis and Alembic; achieved first international breakthrough in Kenya.
  • 2014: Expanded team strength to support seamless project installations.
  • 2016: Bagged turnkey projects in 8 countries; executed a landmark $5 million healthcare project with Nairobi West Hospital.
  • 2018: Expanded capabilities with cleanroom partitions and electrical panels; advanced into turnkey integration and design consultancy.
  • 2020: Strengthened global presence with footprints in 12+ countries; upgraded facilities.
  • 2022: Expanded into a 100,000 sq. ft. facility and initiated turnkey oncology projects.
  • 2024: Successfully listed on NSE Emerge, marking a new phase of growth, visibility, and governance.
  • 2025: Achieved revenue of Rs 131.42 crore.
  • 2025: Entered strategic international markets of Iraq and Algeria.

You have 4 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now